---
title: "Hengbao Co., LTD. released its performance for the first half of the year, with a net profit attributable to shareholders of 35.3541 million yuan, a decrease of 44.41%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254670591.md"
description: "Hengbao Co., LTD. released its semi-annual report for 2025, with operating revenue of 430 million yuan, a year-on-year decrease of 8.64%; net profit attributable to the parent company was 35.3541 million yuan, a year-on-year decline of 44.41%; net profit excluding non-recurring gains and losses was 22.5818 million yuan, a year-on-year decrease of 50.06%; basic earnings per share were 0.0499 yuan"
datetime: "2025-08-26T16:41:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254670591.md)
  - [en](https://longbridge.com/en/news/254670591.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254670591.md)
generator: "portal-rs"
---

# Hengbao Co., LTD. released its performance for the first half of the year, with a net profit attributable to shareholders of 35.3541 million yuan, a decrease of 44.41%

According to the Zhitong Finance APP, Hengbao Co., LTD. (002104.SZ) released its semi-annual report for 2025, with operating revenue of 430 million yuan, a year-on-year decrease of 8.64%. The net profit attributable to shareholders of the listed company was 35.3541 million yuan, a year-on-year decrease of 44.41%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 22.5818 million yuan, a year-on-year decrease of 50.06%. The basic earnings per share were 0.0499 yuan

### Related Stocks

- [002104.CN](https://longbridge.com/en/quote/002104.CN.md)

## Related News & Research

- ["July Was A Bad Month": Jane Street Lost $15 Billion In First Down Month In A Decade](https://longbridge.com/en/news/296131995.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [JD Sports cuts profit forecast as Régis Shultz turnaround slows](https://longbridge.com/en/news/296443354.md)
- [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md)
- [05:37 ETGlobal Artist Hajime Sorayama Establishes Sorayama Hajime Estate Co., Ltd. and Announces New Management Structure](https://longbridge.com/en/news/296597923.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**